Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

著者: Slingluff Craig L, Brautigan David L, Molhoek Kerrington R
出版事項 2005-10-01

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

著者: Molhoek, Kerrington R, Brautigan, David L, Slingluff, Craig L
出版事項 2005

Interface of Signal Transduction Inhibition and Immunotherapy in Melanoma

著者: Shada, Amber L., Molhoek, Kerrington R., Slingluff, Craig L.
出版事項 2010

Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T Cell Receptor and is modulated by IL-2

著者: Molhoek, Kerrington R., McSkimming, Chantel C., Olson, Walter C., Brautigan, David L., Slingluff, Craig L.
出版事項 2008

Human melanoma cytolysis by combined inhibition of mTOR and VEGF/VEGFR-2

著者: Molhoek, Kerrington R., Griesemann, Heinrich, Shu, Jianfen, Gershenwald, Jeffrey E., Brautigan, David L., Slingluff, Craig L.
出版事項 2008

Comprehensive analysis of RTK activation in human melanomas reveals autocrine signaling through IGF-1R

著者: Molhoek, Kerrington R., Shada, Amber L., Smolkin, Mark, Chowbina, Sudhir, Papin, Jason, Brautigan, David L., Slingluff, Craig L.
出版事項 2011

Evaluation of Molecular Markers of Mesenchymal Phenotype in Melanoma

著者: Mikesh, Leann M., Kumar, Manish, Erdag, Gulsun, Hogan, Kevin T., Molhoek, Kerrington R., Mayo, Marty W., Slingluff, Craig L.
出版事項 2010

VEGFR-2 Expression in Human Melanoma: Revised Assessment

著者: Molhoek, Kerrington R., Erdag, Gulsun, Rasamny, Jk, Murphy, Cheryl, Deacon, Donna, Patterson, James W., Slingluff, Craig L., Brautigan, David L.
出版事項 2011

MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab

著者: Wagenseller, Aubrey G, Shada, Amber, D’Auria, Kevin M, Murphy, Cheryl, Sun, Dandan, Molhoek, Kerrington R, Papin, Jason A, Dutta, Anindya, Slingluff Jr, Craig L
出版事項 2013

The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptides

著者: Harris, Rebecca C., Chianese-Bullock, Kimberly A., Petroni, Gina R., Schaefer, Jochen T., Brill, Louis B., Molhoek, Kerrington R., Deacon, Donna H., Patterson, James W., Slingluff, Craig L.
出版事項 2012

Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: A Phase II trial (CTEP 7190/Mel47)

著者: Slingluff, Craig L., Petroni, Gina R, Molhoek, Kerrington R., Brautigan, David L., Chianese-Bullock, Kimberly A., Shada, Amber L., Smolkin, Mark E., Olson, Walter C., Gaucher, Alison, Chase, Cheryl Murphy, Grosh, William W., Weiss, Geoffrey R., Wagenseller, Aubrey G., Olszanski, Anthony J., Martin, Lainie, Shea, Sofa M., Erdag, Gulsun, Ram, Prahlad, Gershenwald, Jeffrey E., Weber, Michael J.
出版事項 2013